{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:46:16Z","timestamp":1751294776723},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,5]]},"DOI":"10.7759\/cureus.31125","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T15:16:10Z","timestamp":1667661370000},"source":"Crossref","is-referenced-by-count":2,"title":["Acute Hypersensitivity Reaction After Casirivimab\/Imdevimab Infusion in a COVID-19-Positive Young Male: Myopericarditis or Kounis Syndrome?"],"prefix":"10.7759","author":[{"given":"Jose A","family":"Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Aragon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Arredondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Percy M","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olabiyi O","family":"Akala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Menowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel","volume":"385","author":"Mevorach D","year":"2021","unstructured":"Mevorach D, Anis E, Cedar N, et al.. Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel. N Engl J Med. 2021, 385:2140-9. 10.1056\/NEJMoa2109730","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021, 144:471-84. 10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4161\/onci.27987","article-title":"Adverse cardiac events to monoclonal antibodies used for cancer therapy: the risk of Kounis syndrome","volume":"3","author":"Kounis NG","year":"2014","unstructured":"Kounis NG, Soufras GD, Tsigkas G, Hahalis G. Adverse cardiac events to monoclonal antibodies used for cancer therapy: the risk of Kounis syndrome. Oncoimmunology. 2014, 3:e27987. 10.4161\/onci.27987","journal-title":"Oncoimmunology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.10.053","article-title":"Myopericarditis: etiology, management, and prognosis","volume":"127","author":"Imazio M","year":"2008","unstructured":"Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int J Cardiol. 2008, 127:17-26. 10.1016\/j.ijcard.2007.10.053","journal-title":"Int J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034497","article-title":"Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology","volume":"140","author":"Bonaca MP","year":"2019","unstructured":"Bonaca MP, Olenchock BA, Salem JE, et al.. Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology. Circulation. 2019, 140:80-91. 10.1161\/CIRCULATIONAHA.118.034497","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2217\/fca.11.63","article-title":"Kounis syndrome: a new twist on an old disease","volume":"7","author":"Kounis NG","year":"2011","unstructured":"Kounis NG, Mazarakis A, Tsigkas G, Giannopoulos S, Goudevenos J. Kounis syndrome: a new twist on an old disease. Future Cardiol. 2011, 7:805-24. 10.2217\/fca.11.63","journal-title":"Future Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with covid-19","volume":"384","author":"Weinreich DM","year":"2021","unstructured":"Weinreich DM, Sivapalasingam S, Norton T, et al.. REGN-COV2, a neutralizing antibody cocktail, in outpatients with covid-19. N Engl J Med. 2021, 384:238-51. 10.1056\/NEJMoa2035002","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/122926-acute-hypersensitivity-reaction-after-casirivimabimdevimab-infusion-in-a-covid-19-positive-young-male-myopericarditis-or-kounis-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:59Z","timestamp":1707508019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/122926-acute-hypersensitivity-reaction-after-casirivimabimdevimab-infusion-in-a-covid-19-positive-young-male-myopericarditis-or-kounis-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.31125","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,5]]}}}